BPC 157 trifluoroacetate salt 95% (HPLC) Sigma Aldrich BPC 157 Peptide Therapy Beverly Hills Tissue & Gut Repair Augmentation of Mast Cell Stability, a Therapeutic Strategy for Idiopathic Pulmonary Fibrosis Read this paper describing a large case series of patients with mast cell activation syndrome (MCAS) and comorbidities, whose MCAS associated symptoms improved significantly on GLP1 agonists. To summarize: 47